Tradestie Institutional Equity Comparison Engine

VIVS vs MTLS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MTLS Overall Edge

MTLS Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Materialise NV (MTLS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VIVS trades at N/M Forward P/E with -10117.0% operating margin (-51.4% YoY revenue) versus MTLS at N/M Forward P/E and 3.4% operating margin (+2.1% YoY). In options structure, VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against MTLS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MTLS
VIVS N/M vs MTLS N/M Fwd P/E
Growth & Margin Winner MTLS
Op Margin -10117.0% vs 3.4% ยท YoY -51.4% vs +2.1%
Momentum & Technical Winner MTLS
1Y -87.0% vs +1.4% ยท 52W Pos 5% vs 38%
Options & Structure Winner MTLS
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
39.0 / 100 SELL
Tech 5.0 Fund 47.0 Flow 50.0 Mom 60.0
MTLS NASDAQ
Materialise NV
Services-Prepackaged Software
$6.31
-0.79% 1D
Market Cap $371.1M
1M Return -25.5%
1Y Return +1.45%
Forward P/E N/M
Unified AI Score
64.7 / 100 BUY
Tech 68.0 Fund 66.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VIVS -86.99% MTLS +1.45% Spread: +88.44 pp (MTLS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VIVS TTM Op. Margin: -10117.0% MTLS TTM Op. Margin: 3.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VIVS vs MTLS. Trailing 12-month operating profitability (VIVS -10117.0% vs MTLS 3.4%) and valuation multiples (VIVS N/M vs MTLS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VIVS (0) vs MTLS (9)
Institutional Metric VIVS MTLS Criterion Row Winner
Market Capitalization Scale $2.4M $371.1M Larger Scale MTLS
Trailing P/E Ratio Valuation N/M 25.0x Lower Multiple MTLS
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -51.4% +2.1% Higher Growth MTLS
Operating Margin (TTM) Profitability -10117.0% 3.4% Higher Margin MTLS
Net Profit Margin Profitability 0.0% 4.6% Higher Margin MTLS
Return on Equity (ROE) Capital Efficiency -343.1% 5.0% Higher ROE MTLS
52-Week Range Position Momentum 5% ($0โ€“$3) 38% ($5โ€“$9) Stronger Trend MTLS
Beta / 30D Volatility Risk Regime 0.83ฮฒ ยท 480% Vol 1.12ฮฒ ยท 87% Vol Lower Realized Risk MTLS
Unified Institutional Score Composite Signal 39.0 / 100 (SELL) 64.7 / 100 (BUY) Higher Composite MTLS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VIVS vs MTLS Buy Guide
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MTLS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTLS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VIVS nor MTLS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.